Publications | Cervo Brain Research Centre

Export 15 results:

Filters: Keyword is Disease Progression [Clear All Filters]

2020

C. M. Morin, Jarrin, D. C., Ivers, H., Mérette, C., LeBlanc, M., and Savard, J., “Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years.”, JAMA Netw Open, vol. 3, no. 11, p. e2018782, 2020.

2014

P. Patel, Kriz, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., and J-P Julien, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.

J. G. Ellis, Perlis, M. L., Bastien, C. H., Gardani, M., and Espie, C. A., “The natural history of insomnia: acute insomnia and first-onset depression.”, Sleep, vol. 37, no. 1, pp. 97-106, 2014.

2012

J. - N. Audet, Gowing, G., Paradis, R., Soucy, G., and J-P Julien, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.

K. Gravel-Laflamme, Routhier, S., and Macoir, J., “[Non-pharmacological therapies of language deficits in semantic dementia].”, Geriatr Psychol Neuropsychiatr Vieil, vol. 10, no. 4, pp. 427-36, 2012.

2010

F. Gros-Louis, Soucy, G., Larivière, R., and J-P Julien, “Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.”, J Neurochem, vol. 113, no. 5, pp. 1188-99, 2010.

J. - N. Audet, Gowing, G., and J-P Julien, “Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.”, Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.

2009

C. M. Morin, Bélanger, L., LeBlanc, M., Ivers, H., Savard, J., Espie, C. A., Mérette, C., Baillargeon, L., and Grégoire, J. - P., “The natural history of insomnia: a population-based 3-year longitudinal study.”, Arch Intern Med, vol. 169, no. 5, pp. 447-53, 2009.

M. Simard, Hudon, C., and van Reekum, R., “Psychological distress and risk for dementia.”, Curr Psychiatry Rep, vol. 11, no. 1, pp. 41-7, 2009.

2008

G. Gowing, Philips, T., Van Wijmeersch, B., Audet, J. - N., Dewil, M., Van Den Bosch, L., Billiau, A. D., Robberecht, W., and J-P Julien, “Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.

2007

C. Haenggeli, J-P Julien, R Mosley, L., Perez, N., Dhar, A., Gendelman, H. E., and Rothstein, J. D., “Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.”, Neurobiol Dis, vol. 26, no. 1, pp. 146-52, 2007.

2004

M. Dang Nguyen, D'Aigle, T., Gowing, G., J-P Julien, and Rivest, S., “Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.”, J Neurosci, vol. 24, no. 6, pp. 1340-9, 2004.

2003

M. Dang Nguyen, Boudreau, M., Kriz, J., Couillard-Després, S., Kaplan, D. R., and J-P Julien, “Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.”, J Neurosci, vol. 23, no. 6, pp. 2131-40, 2003.

S. Fecteau, Mottron, L., Berthiaume, C., and Burack, J. A., “Developmental changes of autistic symptoms.”, Autism, vol. 7, no. 3, pp. 255-68, 2003.

2002

J. Kriz, Nguyen, M. Dang, and J-P Julien, “Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.”, Neurobiol Dis, vol. 10, no. 3, pp. 268-78, 2002.

Funding / Support / Partners

© Gouvernement du Québec